Rania S Moawad

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 4

Top Topics

Breast Cancer Cells

Signaling Pathway

Transforming Growth Factor

Rheumatoid Arthritis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Amal Al-Shahat, Mohey A E Hulail, Nada M M Soliman, Tarek Khamis, Liana Mihaela Fericean, Ahmed Hamed Arisha, Rania S Moawad
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats. Pharmaceutics 14 (12) (2022)
Amal Al-Shahat, Mohey A E Hulail, Nada M M Soliman, Tarek Khamis, Liana Mihaela Fericean, Ahmed Hamed Arisha, Rania S Moawad
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats. Pharmaceutics 14 (12) (2022)
Amal Al-Shahat, Mohey A E Hulail, Nada M M Soliman, Tarek Khamis, Liana Mihaela Fericean, Ahmed Hamed Arisha, Rania S Moawad
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats. Pharmaceutics 14 (12) (2022)
Amal Al-Shahat, Mohey A E Hulail, Nada M M Soliman, Tarek Khamis, Liana Mihaela Fericean, Ahmed Hamed Arisha, Rania S Moawad
Melatonin Mitigates Cisplatin-Induced Ovarian Dysfunction via Altering Steroidogenesis, Inflammation, Apoptosis, Oxidative Stress, and PTEN/PI3K/Akt/mTOR/AMPK Signaling Pathway in Female Rats. Pharmaceutics 14 (12) (2022)